Literature DB >> 2021637

Intramolecular triplex formation of the purine.purine.pyrimidine type.

F M Chen1.   

Abstract

Six octadecamers with hairpin motifs have been synthesized and investigated for possible intramolecular triplex formation. Electrophoretic, hypochromic, and CD evidence suggest that d(CCCCTTTGGGGTTTGGGG) and d(GGGGTTTGGGGTTTCCCC) can form G.G.C intramolecular triplexes via double hairpin formation in neutral solutions, presumably with the terminal G tract folding back along the groove of the hairpin duplex. In contrast, d(GGGGTTTCCCCTTTGGGG) and the three corresponding 18-mers containing one G and two C tracts each forms a single hairpin duplex with a dangling single strand. The design of the sequences has led to the conclusion that the two G tracts are antiparallel to each other in such a triplex. Magnesium chloride titrations indicate that Mg2+ is not essential for such an intramolecular triplex formation. The main advantage of our constructs when compared to the intermolecular triplex formation is that the shorter triplex stem can be formed in a much lower DNA concentration. The merit of G.G.C triplex, in contrast to that of C+.G.C, lies in the fact that acidic condition is not required in its formation and will, thus, greatly expand our repertoire in the triplex strategy for the recognition and cleavage of duplex DNA. Spectral binding studies with actinomycin D (ACTD) and chromomycin A3 (CHR) as well as fluorescence lifetime measurements with ethidium bromide (EB) suggest that although hairpin duplexes bind these drugs quite well, the intramolecular triplexes bind poorly. Interestingly, the binding densities for the strong-binding hairpins obtained from Scatchard plots are about one ACTD molecule per oligomeric strand, whereas more than two drug molecules are found in the case of CHR, in agreement with the recent NMR studies indicating that CHR binds to DNA in the form of a dimer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2021637     DOI: 10.1021/bi00232a014

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Stabilities of intrastrand pyrimidine motif DNA and RNA triple helices.

Authors:  P R Hoyne; A M Gacy; C T McMurray; L J Maher
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

2.  The vacuum UV CD spectra of G.G.C triplexes.

Authors:  K H Johnson; R H Durland; M E Hogan
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

3.  Recognition of Single-Stranded Nucleic Acids by Triplex Formation: The Binding of Pyrimidine-Rich Sequences.

Authors:  Shaohui Wang; Eric T Kool
Journal:  J Am Chem Soc       Date:  1994-09       Impact factor: 15.419

4.  Kinetic studies on the formation of intermolecular triple helices.

Authors:  H M Paes; K R Fox
Journal:  Nucleic Acids Res       Date:  1997-08-15       Impact factor: 16.971

5.  DNA triple-helix formation on nucleosome-bound poly(dA).poly(dT) tracts.

Authors:  P M Brown; K R Fox
Journal:  Biochem J       Date:  1998-07-15       Impact factor: 3.857

6.  Alternate-strand DNA triple-helix formation using short acridine-linked oligonucleotides.

Authors:  E Washbrook; K R Fox
Journal:  Biochem J       Date:  1994-07-15       Impact factor: 3.857

7.  Triple helix formation at (AT)n adjacent to an oligopurine tract.

Authors:  D M Gowers; K R Fox
Journal:  Nucleic Acids Res       Date:  1998-08-15       Impact factor: 16.971

8.  The triplex-hairpin transition in cytosine-rich DNA.

Authors:  Anton S Petrov; Gene Lamm; George R Pack
Journal:  Biophys J       Date:  2004-09-17       Impact factor: 4.033

9.  Comparison of antiparallel A.AT and T.AT triplets within an alternate strand DNA triple helix.

Authors:  E Washbrook; K R Fox
Journal:  Nucleic Acids Res       Date:  1994-09-25       Impact factor: 16.971

10.  Formation of DNA triple helices incorporating blocks of G.GC and T.AT triplets using short acridine-linked oligonucleotides.

Authors:  K R Fox
Journal:  Nucleic Acids Res       Date:  1994-06-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.